Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...

Eliran Toren, CEO, MSolutions discusses what to expect in Barcelona next month. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. ISE 2026 is set ...

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

Inside the human chest, a tireless engine performs a rhythmic masterpiece roughly one hundred thousand times a day. If you ...

The competing risk of nonstroke mortality may limit the potential benefit of stroke prophylaxis therapy in patients with atrial fibrillation or atrial flutter AF. Among a total of 1 883 759 Medicare ...

Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow BOSTON--(BUSINESS WIRE)--#AFSymposium2026--Vektor ...

The competing risk of nonstroke mortality may limit the potential benefit of stroke prophylaxis therapy in patients with atrial fibrillation or atrial flutter AF. We developed a novel risk ...

This population-based nested case-control study analyzed data from the Korean National Health Insurance Corporation (2002–2019). Adults aged ≥19 years with at least three years of recorded claims were ...

This project is a starting point for a Flutter application.

In his early 20s, Alec Burdette had a leadless pacemaker installed to prevent his heart rate from getting too low, a rare condition for someone his age. His heart rhythm disorder, atrial flutter, is ...